The following information was accurate at the time of posting, but may be superceded by subsequent disclosure.
Dec 15, 2003Dec 08, 2003
INEX Releases Onco TCS Data at ASH
Dec 02, 2003
INEX Submits Second Section of NDA
Oct 30, 2003
INEX Releases Third Quarter 2003 Operating Results
Oct 27, 2003
Q3 2003 Conference Call Notification
Sep 30, 2003
INEX Initiates Rolling NDA Submission for Onco TCS
Sep 09, 2003
Inex Pharmaceuticals Announces New Board Members
Jul 31, 2003
INEX Receives Proceeds from Over Allotment Option
Jul 31, 2003
INEX Releases Second Quarter 2003 Operating Results
Jul 28, 2003
INEX Q2 2003 Conference Call Notification
Jul 17, 2003
INEX Closes $25.1 M Bought Deal Financing
Jul 10, 2003
INEX Files Final Prospectus for Bought Deal Financing
Jun 30, 2003
INEX Files Preliminary Prospectus for Bought Deal Financing
Jun 26, 2003
INEX announces $25.1 Million Bought Deal Financing
Jun 25, 2003
Final Data Confirms Onco TCS Pivotal Results
Jun 24, 2003
INEX Conference Call Notification-Onco TCS Final Data
Jun 17, 2003
INEX Provides Timeline for Upcoming Milestones
May 01, 2003
INEX Releases First Quarter 2003 Operating Results
Apr 24, 2003
INEX conference call notification for Q1 2003
Apr 16, 2003
INEX Announces IND filing by GSK
Apr 04, 2003
INEX Selects Vinorelbine TCS as Third Targeted Chemotherapy Product
Apr 03, 2003
INEX Regains 100% Ownership of Lead Product Onco TCS
Mar 12, 2003
INEX Releases 2002 Results
